TABLE 1.
Viral, immunological, and clinical data of individuals participating in the study
| Patient | CD4+ T cell count (per mm3 of blood) | IUPM | No. of isolates | Clones (%) | MPD | Tropism | Time (yrs) before controlled viremia | Effective treatment duration (yrs) |
|---|---|---|---|---|---|---|---|---|
| M | 1,022 | 2.05 | 5 | 0 | NA | CCR5 | 1 | 7 |
| X | 612 | 21.5 | 9 | 25 | 0.008 | CCR5 | 1.2 | 9.3 |
| AE | 982 | 8.4 | 8 | 50 | 0.014 | CCR5 | 9.5 | 18 |
| V | 757 | 1.57 | 5 | 60 | 0.016 | CCR5 & CXCR4 | 5 | 21 |
| S | 354 | 0.31 | 4 | 0 | 0.024 | CCR5 | 7.5 | 2 |
| K | 576 | 1.58 | 10 | 0 | 0.031 | CXCR4 | 14.2 | 6.2 |
| T | 913 | 9.04 | 6 | 50 | 0.031 | CCR5 & CXCR4 | 20 | 12.7 |
| AB | 681 | 1.54 | 14 | 57 | 0.052 | CCR5 & CXCR4 | 20 | 9 |